2m 2m 2m 2m 2m 2m 2m
REPLIMUNE GRP (REPL)
NASDAQ
$14.77-$0.004 (-0.03%)
Price as of Aug 21, 2026 7:58 PM EDT- $1.4BMarket Cap
- 160.49%1-Year Change
- BiotechnologyIndustry
REPLIMUNE GRP (REPL)
$14.77-$0.004 (-0.03%)
REPL | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $14.77 | ||
Change | +$0.72 (+5.12%) | ||
Open | $13.88 | ||
High | $14.98 | ||
Low | $13.81 | ||
Previous Close | $14.05 | ||
Volume | 2,969,475 | ||
30-Day Average Volume | 7,736,040 | ||
1-Week Change | -1.34% | ||
1-Month Change | 34.27% | ||
1-Year Change | 160.49% | ||
3-Year Change | -25.03% | ||
5-Year Change | -51.04% | ||
Fundamentals | |||
Shares Outstanding | 94.2M | ||
Total Assets | $252.4M | ||
Market Cap | $1.4B | ||
Enterprise Value | $1.3B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$69.8M | ||
Free Cash Flow | -$75.7M | ||
EBIT | -$67.2M | ||
EBITDA | -$66.2M | ||
Net Working Capital | $162.4M | ||
EPS | -$0.72 | ||
Enterprise Value/EBITDA | -19 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 13 | ||
P/E | -21 | ||
PEG | -3 | ||
Price/Free Cash Flow | -18 | ||
Price/Operating Cash Flow | -18 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 15 : 1 | ||
Last Split Date | 12/01/2010 | ||
Earnings & Revenue